A double-blind, randomized, comparative study of Dysport® vs. Botox® in primary palmar hyperhidrosis

British Journal of Dermatology

Volumn 149, Issue 5, 2003, Pages 1041-1045

  Simonetta Moreau, M ^a   Cauhepe, C ^a   Magues, J P ^a   Senard, J M ^b  

^a CHU PURPAN   (France)

^b INSERM   (France)

Author keywords

Botulinum toxin A; Intradermal injections; Palmar hyperhidrosis

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERHIDROSIS; INCIDENCE; INJECTION SITE; MALE; MUSCLE WEAKNESS; PRIMARY PALMAR HYPERHIDROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SWEATING; THUMB; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 0346121328     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05620.x     Document Type: Article

References (15)

1. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. Br Med J 2001; 323: 596-9.
2. Heckman M, Ceballos-Baumann AO, Plewig G. Botulinum toxin type A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001; 344: 488-93.
3. Schnider P, Binder M, Auff E et al. Double blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol 1997; 136: 548-52.
4. Saadia D, Voustianouk A, Wang AK, Kaufmann H. Botulinum toxin type A in primary palmar hyperhidrosis. Randomized, single-blind, two-dose study. Neurology 2001; 57: 2095-9.
5. Brin MF, Blitzer A. Botulinum toxin: dangerous terminology errors. J R Soc Med 1993; 86: 493-4.
6. Marion MH, Sheehy M, Sangla S et al. Dose standardisation of botulinum toxin. J Neurol Neurosurg Psychiatry 1995; 59: 102-3.
7. Durif F. Clinical bioequivalence of current commercial preparations of botulinum toxin. Eur Neurol 1995; 2: 17-18.
8. Sampaio C, Ferreira J, Simoes F et al. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin A - Dysport and Botox - assuming a ratio of 4 : 1. Mov Disord 1997; 12: 1013-18.
9. Odergren T, Hjaltason H, Kaakkola S et al. A double-blind, randomized parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neural Neurosurg Psychiatry 1998; 64: 6-12.
10. Ranoux D, Gury C, Fondarai J et al. Respective potencies of Botox and Dysport: a double blind, randomized, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 2002; 72: 459-62.
11. Sato KT, Richardson A, Timm DE, Sato K. One-step iodine starch method for direct visualization of sweating. Am J Med Sci 1988; 295: 528-31.
12. Solomon BA, Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol 2000; 42: 1026-9.
13. Swartling C, Naver H, Lindberg M. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol 2001; 8: 247-52.
14. Schnider P, Moraru E, Kittler H et al. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol 2001; 145: 289-93.
15. Moore AP. General and clinical aspects of treatment with botulinum toxin. In: Handbook of Botulinum Toxin Treatment (Moore P. ed.). Oxford: Blackwell Science, 1995; 28-53.